BenevolentAI: BenevolentAI (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery.
⚠️ This profile was automatically generated by the AYA bot. Information may be inaccurate. Claim this profile to correct and certify your data.
Identification
* This score measures how readable the company is by AIs (ChatGPT, Gemini, Claude...). The higher the score, the more visible and recommendable the company is.
Public Key (AYA ID)
b208ff1e-c1e3-5ae8-91fa-b04e4b2312a3
Issue date
2 juin 2026
Validity
—
Last modified: 2 juin 2026
Semantic Data (AI)
"BenevolentAI (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery."
Indexed Keywords
Supported Protocols
- ✓ JSON-LD Structure
- ✓ ASR v3.0 Standard
Related entities
Other entities in the same sector or country
Secured by AYO Consensus • Swiss Hosting